Life Sciences: Regulatory | UK

Arnold & Porter expertly navigates the complex regulatory framework associated with pharmaceuticals and life sciences, and is frequently called upon to challenge decisions made by regulatory agencies. Its leading product liability practice defends pharmaceutical and medical device manufacturers in sensitive and closely watched disputes. The firm works closely with its competition practice to advise pharmaceutical companies on dawn raids and judicial reviews.

Covington & Burling is a standout practice for complex regulatory matters. It represents drug makers in agency investigations and judicial review cases, and advises life sciences companies large and small on corporate and commercial transactions, including licence agreements, M&A deals and securities offerings. It is also recommended for advice on data privacy. The dispute resolution group handles a variety of contentious matters in the life sciences sector.

Hogan Lovells has a celebrated patent litigation practice which acts largely for innovators in pharmaceuticals, biotechnology and medical devices. It is also one of the finest product liability defence practices serving the sector. The team is supported by the Hogan Lovells Science Unit, postdoctoral scientists who advise the legal team on complex technical issues. It is also noted for its transatlantic capability, complemented by its FDA practice in Washington, DC.

Sidley Austin has an established regulatory practice in the life sciences space. The team provides EU and UK regulatory advise to clients across different regulatory issues including market access strategy, and general compliance. It also communicates with the European Medicines Agency (EMA) and its committees on behalf of clients.

Taylor Wessing has an excellent transactional practice built on years of commitment to the sector, advising on collaboration, licensing, corporate and venture capital deals. It has a powerful patent litigation offering acting for generics and also branded manufacturers, which has pioneering experience handling cases involving biosimilar products. The team is also recommended for EPO patent oppositions.